MX2009010387A - Relleno de vacio inyectable para el aumento de tejido blando. - Google Patents

Relleno de vacio inyectable para el aumento de tejido blando.

Info

Publication number
MX2009010387A
MX2009010387A MX2009010387A MX2009010387A MX2009010387A MX 2009010387 A MX2009010387 A MX 2009010387A MX 2009010387 A MX2009010387 A MX 2009010387A MX 2009010387 A MX2009010387 A MX 2009010387A MX 2009010387 A MX2009010387 A MX 2009010387A
Authority
MX
Mexico
Prior art keywords
composition
void filler
soft tissue
present
tissue augmentation
Prior art date
Application number
MX2009010387A
Other languages
English (en)
Inventor
John J Barry
Andreas Goessl
Heinz Gulle
Monika Mangold
Melitta Bilban
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of MX2009010387A publication Critical patent/MX2009010387A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/502—Plasticizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La presente invención enseña una composición a base de fibrina, microporosa inyectable, elástica suave, totalmente reabsorbible para usarse como un lumen y relleno de vacío de tejido blando. La composición de la presente solicitud presenta características físicas, tales como propiedades mecánicas, observadas típicamente en elastómeros y estabilidad mecánica, que es superior a la fibrina sola. Una gama de propiedades de la composición de la presente invención se pueden adaptar finamente y alterar eficazmente mediante el ajuste del tipo y el contenido de las partículas así como del plastificante contenido en la composición de relleno de vacío.
MX2009010387A 2007-03-26 2008-03-25 Relleno de vacio inyectable para el aumento de tejido blando. MX2009010387A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92004307P 2007-03-26 2007-03-26
PCT/US2008/058146 WO2008118913A2 (en) 2007-03-26 2008-03-25 Injectable void filler for soft tissue augmentation

Publications (1)

Publication Number Publication Date
MX2009010387A true MX2009010387A (es) 2009-10-19

Family

ID=39560923

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009010387A MX2009010387A (es) 2007-03-26 2008-03-25 Relleno de vacio inyectable para el aumento de tejido blando.

Country Status (17)

Country Link
US (3) US20080241072A1 (es)
EP (1) EP2136852B1 (es)
JP (2) JP5385257B2 (es)
KR (1) KR101512863B1 (es)
CN (1) CN101678151B (es)
AT (1) ATE542552T1 (es)
AU (1) AU2008230916B2 (es)
BR (1) BRPI0809383B8 (es)
CA (1) CA2682034C (es)
CO (1) CO6241133A2 (es)
DK (1) DK2136852T3 (es)
ES (1) ES2381448T3 (es)
HR (1) HRP20120092T1 (es)
MX (1) MX2009010387A (es)
PL (1) PL2136852T3 (es)
PT (1) PT2136852E (es)
WO (1) WO2008118913A2 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101454028B (zh) 2006-05-26 2014-06-04 巴克斯特国际公司 用于骨质增加的可注射纤维蛋白组合物
DK2021043T3 (da) * 2006-05-26 2011-04-04 Baxter Int Injicerbart fyldstof til knoglehulrum
US8143722B2 (en) 2006-10-05 2012-03-27 Flipchip International, Llc Wafer-level interconnect for high mechanical reliability applications
CA2682034C (en) 2007-03-26 2015-01-27 Baxter International Inc. Injectable void filler for soft tissue augmentation
WO2009081408A2 (en) * 2007-12-26 2009-07-02 Metamorefix Pulverized fibrin clots and pharmaceutical compositions containing them
US8678008B2 (en) 2008-07-30 2014-03-25 Ethicon, Inc Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea
US8556797B2 (en) 2008-07-31 2013-10-15 Ethicon, Inc. Magnetic implants for treating obstructive sleep apnea and methods therefor
US8413661B2 (en) 2008-08-14 2013-04-09 Ethicon, Inc. Methods and devices for treatment of obstructive sleep apnea
US8561616B2 (en) 2008-10-24 2013-10-22 Ethicon, Inc. Methods and devices for the indirect displacement of the hyoid bone for treating obstructive sleep apnea
US8561617B2 (en) 2008-10-30 2013-10-22 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8800567B2 (en) 2008-12-01 2014-08-12 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8783258B2 (en) 2008-12-01 2014-07-22 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8307831B2 (en) 2009-03-16 2012-11-13 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
CA2761903C (en) * 2009-05-28 2018-04-10 Profibrix B.V. Dry powder fibrin sealant
US9877862B2 (en) 2009-10-29 2018-01-30 Ethicon, Inc. Tongue suspension system with hyoid-extender for treating obstructive sleep apnea
US9326886B2 (en) 2009-10-29 2016-05-03 Ethicon, Inc. Fluid filled implants for treating obstructive sleep apnea
US9974683B2 (en) 2009-10-30 2018-05-22 Ethicon, Inc. Flexible implants having internal volume shifting capabilities for treating obstructive sleep apnea
US8632488B2 (en) 2009-12-15 2014-01-21 Ethicon, Inc. Fluid filled implants for treating medical conditions
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
WO2012000930A1 (en) * 2010-06-28 2012-01-05 Bbs-Bioactive Bone Substitutes Oy A method for preparing a bone protein preparation and a bone protein preparation
US8637067B1 (en) * 2011-03-10 2014-01-28 Lifecell Corporation Elastic tissue matrix derived hydrogel
US8905033B2 (en) 2011-09-28 2014-12-09 Ethicon, Inc. Modular tissue securement systems
US9161855B2 (en) 2011-10-24 2015-10-20 Ethicon, Inc. Tissue supporting device and method
US8973582B2 (en) 2011-11-30 2015-03-10 Ethicon, Inc. Tongue suspension device and method
US10470760B2 (en) 2011-12-08 2019-11-12 Ethicon, Inc. Modified tissue securement fibers
ES2645082T3 (es) 2012-03-12 2017-12-04 The Regents Of The University Of California Métodos y composiciones de tratamiento de heridas y reducción del riesgo de hernias incisionales
US9173766B2 (en) 2012-06-01 2015-11-03 Ethicon, Inc. Systems and methods to treat upper pharyngeal airway of obstructive sleep apnea patients
US20150258249A1 (en) * 2012-10-18 2015-09-17 Mayo Foundation For Medical Education And Research Techniques for treatment of abscesses
US20160303281A1 (en) 2015-04-17 2016-10-20 Rochal Industries, Llc Composition and kits for pseudoplastic microgel matrices
EP3370788A4 (en) * 2015-11-02 2019-07-31 Nanofiber Solutions, LLC ELECTRO-spun fibers with contrast agents and method for producing same
TWI727174B (zh) * 2017-05-30 2021-05-11 荷蘭商阿克法Ｉｐ有限公司 新穎的再吸收性生物可降解醫藥及化粧品組合物
JP7297739B2 (ja) * 2017-10-18 2023-06-26 ライフセル コーポレーション 脂肪組織製品および製造方法
WO2019079672A1 (en) 2017-10-19 2019-04-25 Lifecell Corporation ACELLULAR TISSUE MATRIX PRODUCTS FLUIDS AND METHODS OF PRODUCTION
CN114409734B (zh) * 2022-01-25 2023-05-12 四川大学华西医院 一种可诱导局部麻醉药生物矿化的自组装短肽及其制得的长效局部麻醉和镇痛药物制剂
CN114573660B (zh) * 2022-03-15 2023-06-13 四川大学华西医院 一种自组装短肽及其诱导局部麻醉药生物矿化制得的长效局部麻醉和镇痛药物制剂

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166263A1 (en) 1984-05-31 1986-01-02 Green Cross Corporation Filler composition for filling in defect or hollow portion of bone and kit or set for the preparation of the filler composition
US4696812A (en) * 1985-10-28 1987-09-29 Warner-Lambert Company Thrombin preparations
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
FR2715853B1 (fr) 1994-02-08 1996-04-26 Centre Nat Rech Scient Composition pour bio-matériau; procédé de préparation.
US6287341B1 (en) * 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US5702715A (en) * 1995-10-27 1997-12-30 Drying Technology Reinforced biological sealants
US5752974A (en) 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
US5782917A (en) * 1996-02-26 1998-07-21 Sunmed, Inc. Intramedullary bone plug
US20010016646A1 (en) * 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
US7041641B2 (en) * 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
EP0993311B1 (en) * 1997-06-18 2012-11-14 Angiotech Pharmaceuticals (US), Inc. Compositions containing thrombin and microfibrillar collagen, and methods for preparation and use thereof
WO2000007639A1 (en) 1998-08-07 2000-02-17 Tissue Engineering, Inc. Bone precursor compositions
US6605294B2 (en) * 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6607535B1 (en) * 1999-02-04 2003-08-19 Kwan-Ho Chan Universal bone cement plug and method of use
DE19956503A1 (de) * 1999-11-24 2001-06-21 Universitaetsklinikum Freiburg Spritzbares Knochenersatzmaterial
SE517168C2 (sv) * 2000-07-17 2002-04-23 Bone Support Ab En komposition för ett injicerbart ersättningsmaterial för benmineral
US20050136038A1 (en) * 2001-10-02 2005-06-23 Isotis N.V. Injectable calcium salt bone filler comprising cells
PT1829565E (pt) 2001-12-20 2010-04-26 Bone Support Ab Novo substituto mineral de osso
SE522098C2 (sv) * 2001-12-20 2004-01-13 Bone Support Ab Ett nytt benmineralsubstitut
US7341716B2 (en) * 2002-04-12 2008-03-11 Boston Scientific Scimed, Inc. Occlusive composition
US7135027B2 (en) * 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions
US20050220882A1 (en) 2004-03-04 2005-10-06 Wilson Pritchard Materials for medical implants and occlusive devices
US7621952B2 (en) * 2004-06-07 2009-11-24 Dfine, Inc. Implants and methods for treating bone
WO2006073711A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
MX2007008319A (es) 2005-01-06 2007-10-04 Kuros Biosurgery Ag Matrices suplementadas para la reparacion de fracturas oseas.
DK2021043T3 (da) * 2006-05-26 2011-04-04 Baxter Int Injicerbart fyldstof til knoglehulrum
CN101454028B (zh) * 2006-05-26 2014-06-04 巴克斯特国际公司 用于骨质增加的可注射纤维蛋白组合物
CA2682034C (en) * 2007-03-26 2015-01-27 Baxter International Inc. Injectable void filler for soft tissue augmentation

Also Published As

Publication number Publication date
CO6241133A2 (es) 2011-01-20
AU2008230916B2 (en) 2013-10-03
CN101678151A (zh) 2010-03-24
US20110117027A1 (en) 2011-05-19
HRP20120092T1 (hr) 2012-02-29
EP2136852B1 (en) 2012-01-25
JP5385257B2 (ja) 2014-01-08
BRPI0809383A2 (pt) 2014-09-09
DK2136852T3 (da) 2012-04-16
PL2136852T3 (pl) 2012-07-31
EP2136852A2 (en) 2009-12-30
US20080241072A1 (en) 2008-10-02
JP2010522617A (ja) 2010-07-08
BRPI0809383B8 (pt) 2021-06-22
KR101512863B1 (ko) 2015-04-16
CA2682034C (en) 2015-01-27
AU2008230916A1 (en) 2008-10-02
ES2381448T3 (es) 2012-05-28
WO2008118913A3 (en) 2009-12-03
BRPI0809383B1 (pt) 2018-10-30
US9278160B2 (en) 2016-03-08
WO2008118913A2 (en) 2008-10-02
KR20090122492A (ko) 2009-11-30
CA2682034A1 (en) 2008-10-02
ATE542552T1 (de) 2012-02-15
US20130209370A1 (en) 2013-08-15
JP2013138947A (ja) 2013-07-18
US8377420B2 (en) 2013-02-19
CN101678151B (zh) 2014-04-16
PT2136852E (pt) 2012-02-08

Similar Documents

Publication Publication Date Title
PL2136852T3 (pl) Wstrzykiwalny wypełniacz pustych przestrzeni do augmentacji tkanek miękkich
GB2479515A (en) Compositions with reduced dimer formation
AU2016204344A1 (en) Improved methods and compositions for wound healing
EP2009037A3 (en) Foam control for synthetic adhesive/sealant
EP2528578A4 (en) DENTAL COMPOSITION USING A CALCIUM SOURCE
MX2012001800A (es) Composicion para el cuidado oral que comprende agente sesquiterpenoide y antimicrobiano.
MY150613A (en) Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses
ZA200903305B (en) Concentrated Surfactant Compositions
EP2314323A3 (en) Bioabsorbable surgical composition
WO2012008722A3 (ko) 조직 증강용 충전 조성물
PL2029184T3 (pl) Wstrzykiwalna kompozycja do augmentacji kości
PT2291174E (pt) Composição fluida compreendendo composições de oligómeropolímero biocompatíveis
MX2009008054A (es) Composicion de goma de mascar de regiones multiples que incluye una region de goma de isomaltitol.
MX2010008910A (es) Uso de alternano como agente espesante y composiciones de agente espesante que contienen alternano y otro agente espesante.
EA201200253A1 (ru) Композиция для лечения муковисцидоза
IN2012DN00639A (es)
UA96076C2 (en) Use of trans-clomiphene
MX354910B (es) Uso del glicerol como agente mejorador del caracter autodispersante de una materia mineral destinada a una composicion acuosa.
DK2021043T3 (da) Injicerbart fyldstof til knoglehulrum
PL2337580T3 (pl) Stabilizowane kompozycje czynnika VIII produkowanego metodami rekombinacji genetycznej
WO2010065908A3 (en) Degradable biomolecule compositions
WO2011100330A3 (en) Compositions and methods for preventing or treating a human parvovirus infection
TW200744641A (en) Long lasting alginate dry eye composition, related methods of manufacture and methods of use
ZA201008160B (en) Compositions for the treatment of hair loss
MX2011009277A (es) Composicion de leucocito activada.

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration